Indchemie Health Specialities Private Limited has a strong commitment to manufacturing quality products. The safety of a pharmaceutical product may not be distinct. The post-effects of drugs when used in combination with other drugs are generally unknown and safety concerned in different groups can be different as in young children, elderly patients, and pregnant women. Therefore, to monitor the safety of its product when the product is available for clinical practice, Indchemie has moral and regulatory responsibility to conduct pharmacovigilance activities.
Indchemie has a pharmacovigilance system to safeguard patient health through efficient and timely identification, collection, assessment, and communication of medicine-related adverse events.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of side effects or any other possible drug-related problems.
Check:Indchemie's Pharmacovigilance Policy
An adverse event is any untoward medical occurrence in a patient following the administration of a pharmaceutical product and does not necessarily have a causal relationship with the administered product.
If you wish to report a suspected adverse reaction/side effect that occurred with our drug, you can do so by choosing any of the following options:
Check: Download the Adverse Event Reporting Form
(If you have any queries in filling out the form, click here to download the guidance document).